An open, multicenter study to evaluate the urodynamic properties of a local implantation of autologous skeletal muscle-derived cells (SMDCs) in female patients with stress urinary incontinence

Trial Profile

An open, multicenter study to evaluate the urodynamic properties of a local implantation of autologous skeletal muscle-derived cells (SMDCs) in female patients with stress urinary incontinence

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Nov 2015

At a glance

  • Drugs ICES 13 (Primary)
  • Indications Stress incontinence
  • Focus Therapeutic Use
  • Acronyms PD
  • Sponsors Innovacell Biotechnologie GmbH
  • Most Recent Events

    • 14 Nov 2015 Status changed from recruiting to completed, as reported by European Clinical Trials Database.
    • 20 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top